<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xie M</submitter><funding>Natural Science Foundation of Hunan Province in China</funding><funding>Hunan Provincial Key R&amp;amp;D Program Project</funding><funding>the National Natural Science Foundation of China</funding><pagination>13101</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9338971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems. Immunopathology believes that abnormal T cell function and excessive production of autoantibodies by B cells are involved in multi-organ damage. Human umbilical cord mesenchymal stem cells (hUCMSCs) therapies have endowed with promise in SLE, while the function of MSC-derived extracellular vesicles (MSC-EVs) was still unclear. Extracellular vesicles (EVs) are subcellular components secreted by a paracellular mechanism and are essentially a group of nanoparticles. EVs play a vital role in cell-to-cell communication by acting as biological transporters. New evidence has shown beneficial effects of MSC-EVs on autoimmune diseases, such as their immunomodulatory properties. In this study, we investigated whe</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Human umbilical cord mesenchymal stem cells derived extracellular vesicles regulate acquired immune response of lupus mouse in vitro.</pubmed_title><pmcid>PMC9338971</pmcid><funding_grant_id>No. 2020SK2084</funding_grant_id><funding_grant_id>No. 82070758</funding_grant_id><funding_grant_id>No. 2019JJ40413</funding_grant_id><pubmed_authors>Tian J</pubmed_authors><pubmed_authors>Hun M</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Xie M</pubmed_authors><pubmed_authors>She Z</pubmed_authors><pubmed_authors>Wen C</pubmed_authors><pubmed_authors>Luo S</pubmed_authors><pubmed_authors>Wan W</pubmed_authors><pubmed_authors>Wu F</pubmed_authors><pubmed_authors>Mao J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human umbilical cord mesenchymal stem cells derived extracellular vesicles regulate acquired immune response of lupus mouse in vitro.</name><description>Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple systems. Immunopathology believes that abnormal T cell function and excessive production of autoantibodies by B cells are involved in multi-organ damage. Human umbilical cord mesenchymal stem cells (hUCMSCs) therapies have endowed with promise in SLE, while the function of MSC-derived extracellular vesicles (MSC-EVs) was still unclear. Extracellular vesicles (EVs) are subcellular components secreted by a paracellular mechanism and are essentially a group of nanoparticles. EVs play a vital role in cell-to-cell communication by acting as biological transporters. New evidence has shown beneficial effects of MSC-EVs on autoimmune diseases, such as their immunomodulatory properties. In this study, we investigated whe</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-04T08:44:58.24Z</modification><creation>2025-04-04T08:44:58.24Z</creation></dates><accession>S-EPMC9338971</accession><cross_references><pubmed>35908050</pubmed><doi>10.1038/s41598-022-17331-8</doi></cross_references></HashMap>